Samsung Biologics Co., Ltd.

About Samsung Biologics Co., Ltd.

Samsung Biologics is an end-to-end CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry.

With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.

Our plants are cGMP compliant with a wide range of bioreactor scales. We are committed to maximizing operational efficiency and enhancing our development and manufacturing capabilities to meet growing market demand. Upon full completion of Plant 4 in the first half of 2023, we will hold a total capacity of 604KL at Bio Campus I, the world’s largest biomanufacturing site, and account for one-fourth of the global CDMO manufacturing capacity.

  • KR
  • 2018
    On CPHI since
  • 4
  • 1000 - 4999
Company types
Biopharmaceutical company
Contract Service
Primary activities
Contract Manufacturer
Contact info
  • 300 Songdo Bio Way (daero), Yeonsu-gu, 21987, Incheon, Korea, Republic of
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from Samsung Biologics Co., Ltd. (8)

  • New plant, Plant 4

    Product New plant, Plant 4

    To fulfill the increasing demand of life-saving solutions for patients' lives all over the world, we decided to drive forward with building our new facility, Plant 4. Our accumulated expertise is implemented with the latest technologies and innovation, so that Plant 4 will be able to serve as part of your ...
  • Samsung Biologics CDO Services

    Product Samsung Biologics CDO Services

    We Make it Work - For Every Molecule. Successful development relies on a deep understanding of a molecule’s unique characteristics. At Samsung Biologics, we have the knowledge and expertise to realize the true potential of your molecule, regardless of its complexity. By taking the right steps through ...
  • Samsung Biologics mRNA Services

    Product Samsung Biologics mRNA Services

    A Trusted Navigator in Your Novel Path to Success- Forging Ahead. Together.

    We offer mRNA drug substance and drug product manufacturing from a single site. Frequent handling of mRNA in multiple locations increases contamination and degradation risks. But when the en...
  • Samsung Biologics DEVELOPICK™

    Product Samsung Biologics DEVELOPICK™

    DEVELOPICK™ is a rapid and agile tool that scores drug candidates based on their developability criteria. With requiring only a small amount of material, it provides early insights into each drug candidate to predict those with the best developability for your next-level therapeutic. 
  • Samsung Biologics S-DUAL

    Product Samsung Biologics S-DUAL

    S-DUAL™ is an innovative platform developed by Samsung Biologics. Having a unique asymmetric design, it allows high binding affinity to produce high titer and purity for outstanding manufacturability. 

    S-DUAL™ is ready to meet your needs and peform with excellence to generate perfect pairing ...
  • Bispecific Antibody Platform, S-DUAL

    Product Bispecific Antibody Platform, S-DUAL

    The choice for your next dual-specific therapeutics
    High titer and purity for outstanding manufacturability • Asymmetric structure • Low immunogenicity risk • Correct HC & LC pairing • Versatile format
  • Developability Assessment Platform, DEVELOPICK

    Product Developability Assessment Platform, DEVELOPICK

    Ensure success from an early stage
    Selecting cancidates with the highest development success rate • Early-stage stability screening & scoring • Recommendation of the most suitable formulation
  • New Plant 4, Future of Biomanufacturing

    Product New Plant 4, Future of Biomanufacturing

    Your Powerhouse for Success
    Our newest plant 4 is GMP ready in just 23 months as committed.

Samsung Biologics Co., Ltd. Resources (23)